Atlas Trials

Exploring the Application of 3D Bioprinting for Personalized Treatment in Pancreatic Ductal Adenocarcinoma

Clinical trial NCT05955092 · UNKNOWN

Trial details

NCT number
NCT05955092
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreatic Ductal Adenocarcinoma
Start date
2022-12-01
Primary completion
2024-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.